Sherley Amendment

Sherley Amendment (1911)

Legislation passed in the US in 1912 in response to the US Supreme Court’s decision in US v Johnson [221 U.S. 488 (1911)], which ruled that the misbranding provisions of the 1906 Pure Food and Drugs Act only prohibited false statements as to the identity of a drug, but did not pertain to false curative or therapeutic statements. The Amendment addressed the lack of enforcement of fraud related to therapeutic claims intended to defraud the purchaser, a standard which was difficult to prove.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
P.S.: In the same spirit, this issue features a tongue-in-cheek celebration/mash-up of the 400th anniversary of the King James Bible and the centenary of the Sherley Amendment, The Good Book of Manufacturing Practice (pp.
One of the most important subsequent changes to the 1906 act was the addition of the Sherley Amendment in response to the ruling of the U.S.
Those of us in the pharmaceutical Industry mark another anniversary--it is 100 years since Congress enacted the Sherley Amendment, which prohibited the labeling of false claims.